Clinical Research Detail Title Of Study A Study of V503 (Multivalent HPV Vaccine) in Preadolescents and Adolescents. This study will evaluate the immunogenicity and tolerability of V503 in preadolescent and adolescent subjects between 9 and 15 years old and demonstrate the consistency of the manufactured vaccine through assessment of 3 different final manufacturing process lots of V503. Disease Condition Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Lesions PAP Test Abnormalities HPV Infections Phase of Trial Phase-3 Discipline Immunology Start date of Trial 8/28/2009 Closing Date of Trial 8/28/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]